A measles-vectored vaccine candidate expressing prefusion-stabilized SARS-CoV-2 spike protein brought to phase I/II clinical trials: protection of African green monkeys from COVID-19 disease

Sham Nambulli(University of Pittsburgh), W. Paul Duprex(University of Pittsburgh)
Journal of Virology
April 2, 2024
10.1128/jvi.01762-23
Cited by 4

Related Papers

Animal models for COVID-19
|Nature|2020|877
Taxonomy of the order Mononegavirales: update 2019
|Archives of Virology|2019|342
Taxonomy of the order Mononegavirales: second update 2018
|Archives of Virology|2019|99
2022 taxonomic update of phylum Negarnaviricota (Riboviria: Orthornavirae), including the large orders Bunyavirales and Mononegavirales
|Archives of Virology|2022|89
Annual (2023) taxonomic update of RNA-directed RNA polymerase-encoding negative-sense RNA viruses (realm Riboviria: kingdom Orthornavirae: phylum Negarnaviricota)
|Journal of General Virology|2023|74